| F0010 |
FAM FLICATM Poly Caspases Assay Kit |
25 Tests |
$161.80 |
| |
FAM-VAD-FMK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0011 |
FAM FLICATM Caspase 1 Assay Kit |
25 Tests |
$161.80 |
| |
FAM-YVAD-FMK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0012 |
FAM FLICATM Caspase 2 Assay Kit |
25 Tests |
$174.40 |
| |
FAM-YDVAD-FMK |
100 Tests |
$488.00 |
| |
|
|
|
| |
|
|
|
| F0013 |
FAM FLICATM Caspase 3 & 7 Assay Kit |
25 Tests |
$161.80 |
| |
FAM-DEVD-FMK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0014 |
FAM FLICATM Caspase 6 Assay Kit |
25 Tests |
$161.80 |
| |
FAM-VEID-FMK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0015 |
FAM FLICATM Caspase 8 Assay Kit |
25 Tests |
$174.40 |
| |
FAM-LETD-FMK |
100 Tests |
$488.00 |
| |
|
|
|
| |
|
|
|
| F0016 |
FAM FLICATM Caspase 9 Assay Kit |
25 Tests |
$174.40 |
| |
FAM-LEHD-FMK |
100 Tests |
$488.00 |
| |
|
|
|
| |
|
|
|
| F0017 |
FAM FLICATM Caspase 10 Assay Kit |
25 Tests |
$174.40 |
| |
FAM-AEVD-FMK |
100 Tests |
$488.00 |
| |
|
|
|
| |
|
|
|
| F0018 |
FAM FLICATM Caspase 13 Assay Kit |
25 Tests |
$161.80 |
| |
FAM-LEED-FMK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0019 |
FAM-Phe-CMK FLISPTM Assay Kit |
25 Tests |
$161.80 |
| |
FFCK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0020 |
FAM-Lys-CMK FLISPTM Assay Kit |
25 Tests |
$161.80 |
| |
FKCK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0021 |
FAM-Leu-CMK FLISPTM Assay Kit |
25 Tests |
$161.80 |
| |
FLCK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0022 |
FAM-Spacer-Phe-CMK FLISPTM Assay Kit |
25 Tests |
$161.80 |
| |
FSFCK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0023 |
FAM-Spacer-Leu-CMK FLISPTM Assay Kit |
25 Tests |
$161.80 |
| |
FSLCK |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0024 |
FAM-Leu-DAP FLISPTM Assay Kit |
25 Tests |
$161.80 |
| |
FLDAP |
100 Tests |
$462.90 |
| |
|
|
|
| |
|
|
|
| F0048 |
Famciclovir |
50 mg |
$43.10 |
| |
C14H19N5O4 FW 321.33 |
100 mg |
$72.40 |
| |
Antiviral agent that is an ester of penciclovir for improved absorption. |
500 mg |
$301.40 |
| |
Enright AM, Prober C. Herpes. 10:32-7 (2003). |
|
|
| |
Lilie HM, Wassilew S. Drugs Aging. 20:561-70 (2003). |
|
|
| |
|
|
|
| F0150 |
Famotidine |
500 mg |
$34.50 |
| |
C8H15N7O2S3 FW 337.45 [76824-35-6] |
1 g |
$55.20 |
| |
An antiulcerative agent that has an immunomodulating effect. Effective in |
5 g |
$200.10 |
| |
the prevention and control of chemotherapy-induced gastric mucosal injury. |
|
|
| |
Hahm KB, Kim WH, Lee SI et al. Scand J Gastroenterol. 30:265-71 (1995). |
|
|
| |
Mori K, Tominaga K, Yokoyama K et al. J Cancer Res Clin Oncol. 121:367-70 (1995). |
|
|
| |
|
|
|
| F0268 |
Farnesol |
50 ml |
$82.50 |
| |
C15H26O FW 222.37 [4602-84-0] |
100 ml |
$133.50 |
| |
Polyprenyl alcohol found in plant essential oils. Induces apoptosis in cell cultures. |
|
|
| |
Haug JS, Goldner CM, Yazlovitskaya EM et al. Biochim Biophys Acta. 1223:133-40 (1994). |
|
|
| |
Yaguchi M, Miyazawa K, Katagiri T et al. Leukemia. 11:779-87 (1997). |
|
|
| |
|
|
|
| F1745 |
Felodipine |
50 mg |
$56.00 |
| |
C18H19Cl2NO4 FW 384.25 [72509-76-3] |
100 mg |
$89.60 |
| |
Felodipine is effective at preventing angina pectoris. |
250 mg |
$168.00 |
| |
Detry JM, De Coster PM, Renkin J. Am J Cardiol. 52:453-457 (1983). |
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| F1650 |
Fenbendazole |
5 g |
$27.40 |
| |
C15H13N3O2S FW 299.35 [43210-67-9] |
10 g |
$48.60 |
| |
A highly effective anthelmintic used to control trematodes and cestodes. |
100 g |
$296.10 |
| |
It is a potent CYP1A2 inducer. |
|
|
| |
Baeder C, Bahr H, Christ O et al. Experientia. 30:753-754 (1974). |
|
|
| |
|
|
|
| F1652 |
Fenbufen |
1 g |
$30.50 |
| |
C16H14O3 FW 254.28 [36330-85-5] |
5 g |
$75.90 |
| |
An anti-inflammatory analgesic. |
10 g |
$129.10 |
| |
Child RG, Osterberg AC, Slobida AE et al. J. Pharm Sci 66:466-476 (1977). |
|
|
| |
|
|
|
| F1853 |
Fenofibrate |
5 g |
$33.20 |
| |
C20H21ClO4 FW 360.83 [49562-28-9] |
25 g |
$103.50 |
| |
A hypolipidemic drug useful in prevention of myocardial inflammation and
|
100 g |
$289.90 |
| |
fibrosis. PPARalpha activator that is a potent and well tolerated lipid lowering drug. |
|
|
| |
Diep QN, Benkirane K, Amiri F et al. J Mol Cell Cardiol. 36:295-304 (2004). |
|
|
| |
Roberts WC. Cardiology. 76:169-79 (1989). |
|
|
| |
|
|
|
| F1654 |
Fenoldopam mesylate |
25 mg |
$57.80 |
| |
C16H16ClNO3 FW 305.76 [67227-56-9] |
100 mg |
$182.20 |
| |
A renal vasodilator that stimulates renal vascular dopamine receptors with |
500 mg |
$683.10 |
| |
little effect on the central dopamine receptors. |
|
|
| |
Hahn RA, Wardell JR Jr, Sarau HM, Ridley PT. J. Pharm & Expt Ther. 223:305-313 (1982). |
|
|
| |
|
|
|
| F1655 |
Fenoprofen |
1 g |
$27.40 |
| |
C15H14O3 FW 242.27 [31879-05-7] |
5 g |
$54.80 |
| |
A NSAID inhibits prostaglandin synthesis and adherence of |
10 g |
$91.20 |
| |
polymorphonuclease leukocytes. It has antiproliferative effects on human colon cancer cells. |
|
|
| |
Venezio FR, DiVincenzo C, Pearlman F, Phair JP. J Infec Diseases. 152:690-694 (1985). |
|
|
| |
Patrono C, Ciabattoni G, Grossi-Belloni D. Pharmacol Res Comm. 6:509-518 (1974). |
|
|
| |
Hixson LJ, Alberts DS, Krutzsch M et al. Cancer Epid Biomark Prev. 3:433-438 (1994). |
|
|
| |
|
|
|
| |
Fenretinide (See N-(4-Hydroxyphenyl)retinamide) |
|
|
| |
|
|
|
| F1854 |
Fenticonazole |
100 mg |
$30.00 |
| |
C24H21Cl2N2OS FW 456.41 [72479-26-6] |
250 mg |
$48.00 |
| |
an azole antifungal drug |
1 g |
$150.00 |
| |
Athow-Frost T A, Current medical research and opinion (1986), 10(2), 107-16 |
|
|
| |
|
|
|
| F1669 |
Ferulic acid |
5 g |
$19.80 |
| |
C10H10O4 FW 194.18 m.p. 168-1710C [1135-24-6] |
25 g |
$62.40 |
| |
A chemopreventive analogue of caffeic acid. |
|
|
| |
Tanaka T, Kojima T, Kawamori T et al. Carcinogenesis 14:1321-1325 (1993). |
|
|
| |
|
|
|
| F1895 |
Fexofenadine Hydrochloride |
25 mg |
$44.80 |
| |
C32H40ClNO4 FW 538.12 [153439-40-8] |
100 mg |
$112.00 |
| |
A non-sedating H1 receptor antagonist that may be useful to treat daily |
500 mg |
$162.40 |
| |
symptoms of eczematous diseases. |
|
|
| |
Bronsky EA, Falliers CJ, Kaiser HB et al. Allergy Asthma Proc. 19:135-141 (1998). |
|
|
| |
Katagiri K, Arakawa S, Hatano Y, Fujiwara S. J Dermatol. 33:75-79 (2006). |
|
|
| |
|
|
|
| F3204 |
Fibrinogen-binding Peptide |
5 mg |
$60.30 |
| |
C25H39N7O8 FW 565.63 |
|
|
| |
|
|
|
| F3205 |
Fibrinogen gamma-chain dodecapeptide |
1 mg |
$71.70 |
| |
C50H80N18O16 FW 1189.29 |
2 mg |
$121.90 |
| |
|
5 mg |
$215.00 |
| |
|
|
|
| F3206 |
Fibrinolysis Inhibiting Factor |
1 mg |
$35.80 |
| |
C18H31N7O5 FW 425.49 |
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| F3208 |
Fibrinopeptide B, human |
1 mg |
$71.70 |
| |
C66H93N19O25 FW 1552.59 |
2 mg |
$121.90 |
| |
|
5 mg |
$215.00 |
| |
|
|
|
| F3209 |
Fibronectin-Binding Protein |
0.5 mg |
$121.90 |
| |
C190H283N49O66 FW 4309.66 |
1 mg |
$207.90 |
| |
Inhibits binding of fibronectin to bacterial cells. |
2.5 mg |
$365.60 |
| |
|
|
|
| |
|
|
|
| F3207 |
Fibronectin CS-1 Peptide |
1 mg |
$53.80 |
| |
C38H64N8O15 FW 872.97 |
2 mg |
$91.40 |
| |
|
5 mg |
$161.30 |
| |
|
|
|
| F3354 |
Finasteride |
100 mg |
$129.20 |
| |
C23H36N2O2 FW 372.54 [[98319-26-7] |
500 mg |
$473.40 |
| |
Finasteride is a synthetic 4-azasteroid. It is a specific inhibitor of the enzyme steroid |
|
|
| |
5-a-reductase which is responsible for the conversion of testosterone into the potent |
|
|
| |
androgen 5a-dihydrotestosterone. |
|
|
| |
Peters DH, Sorkin EM. Drugs 46:177-208 (1993). |
|
|
| |
Gormley GJ. Biomed Pharmacother 49:319-24 (1995). |
|
|
| |
|
|
|
| |
FK506 (See Tacrolimus) |
|
|
| |
|
|
|
| F4400 |
Flag Peptide |
0.5 mg |
$20.20 |
| |
C41H60N10O20 FW 1012.99 |
1 mg |
$33.90 |
| |
|
2.5 mg |
$60.30 |
| |
|
|
|
| F4501 |
Flavanone |
10 g |
$37.90 |
| |
C15H12O2 FW 224.25 [487-26-3] |
25 g |
$85.30 |
| |
Natural flavonoid from plants. Found to inhibit tumor cells in culture. Its oxime |
|
|
| |
derivative induces apoptosis. |
|
|
| |
Kuntz S, Wenzel U, Daniel H. Eur J Nutr. 38:133-42 (1999). |
|
|
| |
|
|
|
| F4502 |
Flavokawain A |
5 mg |
$111.40 |
| |
C18H18O5 FW 314.33 |
10 mg |
$172.10 |
| |
A minor component of kava extract. |
|
|
| |
|
|
|
| |
|
|
|
| F4503 |
Flavokawain B |
5 mg |
$111.40 |
| |
C17H16O4 FW 284.31 |
10 mg |
$172.10 |
| |
A minor component of kava extract. |
|
|
| |
|
|
|
| F4518 |
Fleroxacin |
5 g |
$103.50 |
| |
C17H18F3N3O3 FW 369.34 [79660-72-3] |
10 g |
$165.60 |
| |
An antibacterial agent with antiproliferative effects. |
25 g |
$345.00 |
| |
Ebisuno S, Nishikawa T, Kohjimoto Y et al. Urol Int. 62:150-4 (1999). |
|
|
| |
|
|
|
| F4420 |
Boc-F-L-F-L-F |
5 mg |
$71.70 |
| |
C44H59N5O8 FW 785.99 |
10 mg |
$121.90 |
| |
A fluorescent N-Formyl-peptide receptor antagonist. |
25 mg |
$215.00 |
| |
Johansson B, Wymann MP, Holmgren-Peterson K, Magnusson KE. J Cell Biol. 121:1281-1289 (1993). |
|
|
| |
|
|
|
| F4556 |
Florfenicol |
1 g |
$48.40 |
| |
C12H14Cl2FNO4S FW 358.21 [73231-34-2] |
5 g |
$138.00 |
| |
A potent broad spectrum antimicrobial agent. |
10 g |
$207.00 |
| |
Priebe S, Schwarz S. Antimicrob Agents Chemother. 47:2703-5 (2003). |
|
|
| |
|
|
|
| F4557 |
Floxuridine |
500 mg |
$133.60 |
| |
C9H11FN2O5 FW 246.19 [50-91-9] |
1 g |
$220.20 |
| |
Antitumor agent used in chemotherapy of colon cancer. |
|
|
| |
Bilchik AJ, Wood TF, Chawla SP, Rose DM et al. Clin Colorectal Cancer 1:36-42 (2001). |
|
|
| |
|
|
|
| F4679 |
Flubendazole |
10 g |
$62.20 |
| |
C16H12FN3O3 FW 313.28 [31430-15-6] |
25 g |
$135.30 |
| |
A potent broad spectrum anthelmintic. |
100 g |
$414.00 |
| |
William S, Guirguis F, Nessim NG. Arzneimittelforschung. 53:532-7 (2003). |
|
|
| |
|
|
|
| F4682 |
Fluconazole |
500 mg |
$41.30 |
| |
C13H12F2N6O FW 306.27 [86386-73-4] |
1 g |
$65.40 |
| |
A triazole broad-spectrum antifungal agent. Effective against Candida spp., |
5 g |
$249.80 |
| |
cryptococcus neoformans and dermatophytes. |
|
|
| |
Vincent-Ballereau FN, Patey ON, Lafaix C. Pharm Weekbl Sci. 13:45-57 (1991). |
|
|
| |
Martin MV. J Antimicrob Chemother. 44:429-37 (1999). |
|
|
| |
|
|
|
| F4781 |
Fludarabine |
5 mg |
$56.00 |
| |
2-Fluoroadenine-9-b-D-arabinofuranoside |
10 mg |
$112.00 |
| |
C10H12FN5O4 FW 285.23 [21679-14-1] |
25 mg |
$207.20 |
| |
An adenosine analogue that resists deamination. This analogue shows effective |
|
|
| |
antileukemic activity. |
|
|
| |
Casper ES, Mittelman A, Kelson D, Young CW. Cancer Chemother Pharmacol. 15:233-235 (1985). |
|
|
| |
Warrell RP Jr, Berman E. J Clin Oncol. 4:74-79 (1986). |
|
|
| |
|
|
|
| F4782 |
Fludarabine Phosphate |
5 mg |
$56.00 |
| |
C10H13FN5O7P FW 365.21 [75607-67-9] |
10 mg |
$112.00 |
| |
Highly effective in the treatment of chronic lymphocytic leukemia, producing |
25 mg |
$207.20 |
| |
higher response rates than alkylating agents. It is a purine analog which inhibits |
|
|
| |
DNA synthesis by interfering with ribonucleotide reductase and DNA polymerase. |
|
|
| |
Cazin, B. British Journal of Haematology (2008), 143(1), 54-59. |
|
|
| |
|
|
|
| F4483 |
Flufenamic acid |
10 g |
$18.30 |
| |
C14H10F3NO2 FW 281.23 [530-78-9] |
50 g |
$60.80 |
| |
A NSAID found to be a reversible gap junction blocker. |
|
|
| |
Harks, EG., de Roos, AD., Peters, PH., et al. J. Pharm. Exptal Ther. 298:1033-1041 (2001). |
|
|
| |
|
|
|
| F4580 |
FluM1 A2 (58-66) |
1 mg |
$39.40 |
| |
C49H75N9O11 FW 966.2 |
2 mg |
$66.30 |
| |
|
5 mg |
$118.30 |
| |
|
|
|
| F4681 |
Flumazenil |
25 mg |
$69.00 |
| |
C15H14FN3O3 FW 303.29 [78755-81-4] |
100 mg |
$276.00 |
| |
A benzodiazepine antagonist. |
|
|
| |
Jung HY, Sohn YH, Mason A et al. Clin Neurophysiol.115:325-9 (2004). |
|
|
| |
|
|
|
| F4582 |
Fluocinolone Acetonide |
25 mg |
$22.50 |
| |
C24H30F2O6 FW 452.49 [67-73-2] |
100 mg |
$58.80 |
| |
A synthetic glucocorticoid with anti-inflammatory and anti-carcinogenesis |
250 mg |
$117.00 |
| |
properties. It inhibits tumor promotion in mouse skin when applied with a |
1 g |
$323.70 |
| |
promoting agent at the early stages of promotion. It was also found to inhibit induction |
|
|
| |
of early growth response-1 (Egr-1) gene in SENECAR mice and phospholipid peroxidation in CD1 |
|
|
| |
mice which were exposed to 12-O-tetradecanoyl phorbol-13-acetate (TPA) treatment. |
|
|
| |
Digiovanni J, kruszewski FH, Chenicek KJ. Carcinogenesis. 9:1445-50 (1988). |
|
|
| |
Riggs PK, Rho O, Digiovanni J. Mol Carcinog. 27:247-51 (2000). |
|
|
| |
Beckman JK, Bagheri F, Ji C, Blair IA, Marnett LJ. Carcinogenesis. 15:2937-44 (1994). |
|
|
| |
|
|
|
| F4480 |
5-Fluorouracil |
1 g |
$20.60 |
| |
C4H3FN2O2 FW 130.08 m.p. 280-2820C [51-21-8] |
5 g |
$72.40 |
| |
A pyrimidine antimetabolite. Prevents the biosynthesis of thymidine |
|
|
| |
during DNA synthesis. |
|
|
| |
Ananthan S, In "Cancer Chemotherapeutic Agents" Foye WO, Ed., ACS Professional Ref. pp.49-54, (1995). |
|
|
| |
|
|
|
| F4780 |
Fluoxetine hydrochloride |
1 g |
$38.10 |
| |
C17H18F3NO.HCl FW 345.79 [59333-67-4] |
5 g |
$151.90 |
| |
A specific serotonin uptake inhibitor. It was found to exert inhibitory or stimulating effects |
|
|
| |
on T-lymphocyte proliferation depending on the concentration. |
|
|
| |
Wong DT et al. Life Sci. 15:471 (1974). |
|
|
| |
Edgar VA, Genaro AM, Cremaschi G, Sterin-Borda L. Cell Signalling 10:721-726 (1998). |
|
|
| |
|
|
|
| F4584 |
Fluphenazine |
1 g |
$52.80 |
| |
C22H26F3N3OS FW 437.52 [69-23-8] |
5 g |
$106.60 |
| |
A neuroleptic drug that is a dopamine receptor antagonist. Aacts as an |
25 g |
$439.00 |
| |
antimutagen, which may be explained by its ability to reduce the level of free radicals. |
|
|
| |
Gasiorowski K, Brokos B, Szyba K et al. Mutagenesis. 16:31-8 (2001). |
|
|
| |
Nasello AG, Gidali D, Felicio LF. Pharmacol Biochem Behav. 75:895-901 (2003). |
|
|
| |
|
|
|
| F4583 |
Flupirtine Maleate |
10 mg |
$48.00 |
| |
C15H17FN4O2 FW 304.32 [75507-68-5] |
25 mg |
$100.00 |
| |
Currently under a clinical trial (recruiting phase) as a treatment for Multiple |
100 mg |
$320.00 |
| |
Sclerosis and has been used as an analgesic. |
|
|
| |
Rupalla, Katrin, European Journal of Pharmacology (1995), 294(2/3), 469-73. |
|
|
| |
|
|
|
| F4481 |
Flurbiprofen |
1 g |
$30.10 |
| |
C15H13FO2 FW 244.26 m.p. 114-1170C [5104-49-4] |
5 g |
$109.00 |
| |
A non-steroidal anti-inflammatory agent with potential for colon |
25 g |
$353.70 |
| |
cancer chemoprevention. |
|
|
| |
Wechter WJ, Kantoci D, Murray ED, et al. Cancer Res.,57:4316-4324 (1997) |
|
|
| |
|
|
|
| F4680 |
Flutamide |
1 g |
$26.00 |
| |
C11H11F3N2O3 FW 276.22 [13311-84-7] |
5 g |
$86.10 |
| |
An anti-androgen with chemopreventive properties against bladder and prostate carcinogenesis. |
|
|
| |
It inhibits the expression of transforming growth factor beta-1 (TGF-beta1) which is regulated |
|
|
| |
by testosterone. It is also used to treat prostate cancer. |
|
|
| |
Imad S, Akaza H, Ami y, Koiso K, Ideyama Y, Takenaka T. Eur Urol. 31:360-4 (1997). |
|
|
| |
Xie B, Tsao SW, Wong YC, Breast Cancer Res Treat. 58:227-39 (1999). |
|
|
| |
Fossa SD, Slee PH, Brausi M et al. J Clin Oncol. 19 :62-71 (2001). |
|
|
| |
|
|
|
| F4683 |
Fluticasone Propionate |
10 mg |
$56.00 |
| |
C25H31F3O5S Mol. Wt: 500.57 [80474-14-2] |
25 mg |
$112.00 |
| |
Fluticasone is a synthetic steroid of the glucocorticoid family of drugs, that is |
100 mg |
$364.00 |
| |
used for treating allergic conditions of the nose. Fluticasone mimics the naturally |
|
|
| |
occurring hormone produced by the adrenal glands; cortisone and hypercortisone. |
|
|
| |
Baldwin, C. M. Drugs (2008), 68(12), 1723-1739. |
|
|
| |
Meltzer, E. O. Clinical Therapeutics (2008), 30(2), 271-279. |
|
|
| |
|
|
|
| F4482 |
Fluvastatin sodium |
10 mg |
$65.60 |
| |
C24H25FNNaO4 FW 433.45 |
50 mg |
$246.00 |
| |
An anticholesterol agent.It is a HMG-CoA reductase inhibitor and antioxidant. |
100 mg |
$430.40 |
| |
Sumi D, Hayashi T,Thakur NK. Atherosclerosis. 155:347-57 (2001). |
|
|
| |
Yamamoto A, Ichihara K, Hoshi K. J Pharm Pharmacol. 53:227-32 (2001). |
|
|
| |
Obata T, Ebihara A, Yamanaka Y. Biochim Biophys Acta. 1536:55-63 (2001). |
|
|
| |
|
|
|
| F4856 |
Fmoc-Lys(Boc)-Leu-Lys(Boc) |
1 g |
$985.60 |
| |
C26H35N8O7S Mol Wt: 809.9 |
|
|
| |
|
|
|
| F4859 |
F-M-R-F |
5 mg |
$35.80 |
| |
C29H41N7O5S FW 599.76 |
10 mg |
$60.90 |
| |
|
25 mg |
$107.50 |
| |
|
|
|
| F4857 |
FMRF amide |
1 mg |
$53.80 |
| |
C29H42N8O4S FW 598.76 |
|
|
| |
Molluscan Cardioexcitatory Peptide |
|
|
| |
|
|
|
| F4858 |
FMRF-like peptide from Snail |
1 mg |
$89.60 |
| |
C44H62N11O10 FW 904.03 |
|
|
| |
|
|
|
| F5745 |
Folic Acid |
10 g |
$21.70 |
| |
C19H19N7O6 FW 441.40 [59-30-3] |
50 g |
$90.00 |
| |
Folate is an important cofactor in the transfer of one-carbon moieties and plays a major |
|
|
| |
role in the formation of S-adenosyl methionine, the universal methyl donor, as well as in |
|
|
| |
the synthesis and repair of DNA and RNA. Studies show that folate supplementation |
|
|
| |
supressess colorectal carcinogenesis and reduces the risk of pancreatic and breast cancer. |
|
|
| |
Choi SW, Mason JB. J Nutr. 130:129-32 (2000). |
|
|
| |
Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI. Cancer Res. 60:3191-9 (2000). |
|
|
| |
Kim YI. Nutr. Rev. 57:314-21 (1999). |
|
|
| |
|
|
|
| F5846 |
Folinic Acid Calcium Salt (Leucovorin) |
25 mg |
$25.30 |
| |
C20H23N7O7 FW 473.44 [1492-18-8] |
100 mg |
$69.90 |
| |
The active form of the B complex vitamin, Folate. Leucovorin is used as an |
250 mg |
$228.80 |
| |
antidote to cancer treatment drugs which have an adverse effect on folic |
1 g |
$437.90 |
| |
acid levels, or in combination with chemotherapy. |
|
|
| |
Kuwa K, Sakamoto S, Sassa S et al. Anticancer Res. 19:513-42 (1999). |
|
|
| |
Petak I, Tillman DM, Houghton JA. Clin Cancer Res. 6:4432-41 (2000). |
|
|
| |
See Calcium Folinate, Pentahydrate |
|
|
| |
|
|
|
| F5766 |
Forchlorfenuron (KT-30) |
500 mg |
$60.30 |
| |
C12H10ClN3O FW 247.68 [68157-60-8] |
1 g |
$97.90 |
| |
It is a cytokinin that promotes cell division and cell differentiation. It is used |
5 g |
$376.30 |
| |
as a plant growth regulator that improves fruit size and yield. |
|
|
| |
Shudo K. Yakugaku Zasshi. 114:577-88 (1994). |
|
|
| |
Li C, Bangerth F. J Plant Physiol. 160:1059-63 (2003). |
|
|
| |
|
|
|
| F5769 |
Formestane |
100 mg |
$146.30 |
| |
C19H26O3 FW 302.41 [566-48-3] |
500 mg |
$490.70 |
| |
A steroidal aromatase inhibitor used in the treatment of postmenopausal breast cancer. |
|
|
| |
It is a potential cancer chemopreventive agent for breast cancer. |
|
|
| |
Wiseman LR, Goa KL. Drugs Aging 9:292-306 (1996). |
|
|
| |
Kelloff GJ, Lubet RA, Lieberman R. Cancer Epidemiol Biomarkers Prev. 7:65-78 (1998). |
|
|
| |
|
|
|
| F5770 |
Formononetin |
100 mg |
$68.40 |
| |
C16H12O4 FW 268.26 [485-72-3] |
500 mg |
$205.10 |
| |
Natural isoflavone having estrogenic activity. It binds to hER alpha and |
1 g |
$318.80 |
| |
slightly induces transcription with hER beta. It was found to inhibit lecithin peroxidation induced |
|
|
| |
by superoxide anion generation by xanthine-xanthine oxidase. |
|
|
| |
Morito K, Aomori t, Hirose T et al. Biol Pharmaceutical Bull. 25:48-52 (2002). |
|
|
| |
Toda S, Shiratake Y. Phytother Res. 13:163-165 (1999). |
|
|
| |
|
|
|
| F5868 |
Formoterol Fumarate |
10 mg |
$96.70 |
| |
(C19H24N2O4)2C4H4O4.2H2O FW 840.91 [43229-80-7] |
50 mg |
$414.00 |
| |
Long-acting beta2-adrenergic agent that induces apoptosis through an |
|
|
| |
adrenoreceptor- and cAMP-independent, Ca2+-dependent mechanism. Antiasthmatic. |
|
|
| |
Mamani-Matsuda M, Moynet D, Molimard M et al. Br J Haematol. 124:141-50 (2004). |
|
|
| |
Tashkin DP, Cooper CB. Chest.125:249-59 (2004). |
|
|
| |
|
|
|
| F5869 |
N-Formyl -Met-Ala-Ser |
1 mg |
$35.80 |
| |
C12H21N3O6S FW 335.38 |
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| F5870 |
N-Formyl-Met-Leu-Phe |
5 mg |
$28.70 |
| |
C21H31N3O5S FW 437.6 |
10 mg |
$48.40 |
| |
A bacterial chemotactic peptide. |
25 mg |
$86.00 |
| |
Anton P, O'Connell J, O'Connell D et al. Gut. 42:374-379 (1998). |
|
|
| |
|
|
|
| F5871 |
N-Formyl-Met-Leu-Phe-Lys |
5 mg |
$28.70 |
| |
C27H43N3O6S FW 565.74 |
10 mg |
$48.40 |
| |
|
25 mg |
$86.00 |
| |
|
|
|
| F5872 |
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys |
5 mg |
$57.30 |
| |
C43H65O7N9 FW 824.04 |
10 mg |
$96.80 |
| |
|
25 mg |
$172.00 |
| |
|
|
|
| F5668 |
Forskolin |
1 mg |
$36.30 |
| |
C22H34O7 FW 410.50 [66575-29-9] |
5 mg |
$111.70 |
| |
Activator of adenylate cyclase. |
10 mg |
$172.10 |
| |
Laurenza A et al. Trends Pharm Sci. 10:442-7 (1989). |
|
|
| |
Barber R, Goka TJ. J Cyclic Nucleotide Protein Phos. Res. 10:23-9 (1985). |
|
|
| |
|
|
|
| F5873 |
Foscarnet sodium |
1 g |
$50.40 |
| |
CNa3O5P FW 191.95 [63585-09-1] |
5 g |
$196.00 |
| |
Anti-viral medication used to treat herpes viruses. Structural mimic of the anion |
10 g |
$336.00 |
| |
pyrophosphate the selectively regulates DNA polymerase. |
|
|
| |
Yu, Yan-yan. Zhonghua Ganzangbing Zazhi (2006), 14(11), 814-816. |
|
|
| |
|
|
|
| F5874 |
Fosfomycin Calcium |
5 g |
$56.00 |
| |
C3H5CaO4P FW 176.12 [26016-98-8] |
25 g |
$224.00 |
| |
Acts by inhibiting bacterial wall synthesis by inactivating the enzyme pyruval transferase. |
|
|
| |
Used for treated urinary tract infections and as a wide spectrum antibiotic.transferase. |
|
|
| |
Used for treated urinary tract infections and as a wide spectrum antibiotic. |
|
|
| |
Fujita M. The Japanese journal of antibiotics (1975), 28(3), 314-9. |
|
|
| |
|
|
|
| F5773 |
Fosinopril sodium |
25 mg |
$39.20 |
| |
C30H45NO7P .Na FW 585.64 [88889-14-9] |
100 mg |
$134.40 |
| |
An angiotensin-converting enzyme inhibitor shown to protect the organs in |
250 mg |
$268.80 |
| |
sinoaortic-denervated rats. |
|
|
| |
Duchin KL, Waclawski AP, Tu JI et al. J Clin Pharmacol. 31:58-64 (1991). |
|
|
| |
Tao X, Liu GL. Yao Xue Xue Bao. 38:743-747 (2003). |
|
|
| |
|
|
|
| F5976 |
Fotemustene |
5 mg |
$35.00 |
| |
C9H19ClN3O5P FW 315.69 [92118-27-9] |
25 mg |
$80.00 |
| |
is a nitrosourea alkylating agent that is being investigated for use in the |
100 mg |
$200.00 |
| |
treatment of melanoma. |
|
|
| |
Tas, F., Cancer Chemotherapy and Pharmacology (2008), 62(2), 293-298 |
|
|
| |
|
|
|
| F7657 |
Ftorafur |
250 mg |
$46.60 |
| |
5-Fluoro-1-(tetrahydro-2-furyl)uracil, tegafur |
1 g |
$125.10 |
| |
C8H9FN2O3 FW 200.17 m.p. 167-1690C [17902-23-7] |
|
|
| |
A clinically used antitumor agent related to 5-fluorouracil. Often used in combination |
|
|
| |
with other antineoplastic drugs. |
|
|
| |
Zhuk R. Adv Exp Med Biol. 431:677-80 (1998). |
|
|
| |
Ron IG, Lotan A, Inbar MJ, Chaitchik S. Anticancer Drugs. 7:649-54 (1996). |
|
|
| |
|
|
|
| F8048 |
Fumagillin |
1 mg |
$87.40 |
| |
Amebacilin, fugillin, fumadil B |
5 mg |
$358.40 |
| |
C26H34O7 FW 458.54 [23110-15-8] |
|
|
| |
Antibiotic produced by Aspergillus fumigatus. It is an antiprotozoal. Commonly used |
|
|
| |
to control nosema apis in honey bees. It was found to have antineoplastic activity. |
|
|
| |
It is an inhibitor of angiogenesis. |
|
|
| |
Stepiel H, Grochal M, Zielinski KW. Journal of Endocrinology. 150:99-106 (1996). |
|
|
| |
Rodriguez-Nieto S, Medina MA, Quesada AR. Anticancer Res. 21:3457-3460 (2001). |
|
|
| |
|
|
|
| F8149 |
Fumonisin B1 |
1 mg |
$125.40 |
| |
C34H59NO15 FW 721.8 [116355-83-0] |
5 mg |
$564.50 |
| |
Mycotoxin from Fusarium moniliforme. Induces apoptosis in rat and monkey kidney cells. |
|
|
| |
Wang W, Jones C, Ciacci-Zanella J et al. Proc. Natl Acad Sci. USA. 93:3461-5 (1996). |
|
|
| |
Tolleson WH, Dooley KL, Sheldon WG. Adv. Exp Med Biol. 392:237-50 (1996). |
|
|
| |
|
|
|
| F8150 |
Fumonisin B2 |
1 mg |
$235.20 |
| |
C34H59NO14 FW 705.8 [116355-84-1] |
5 mg |
$981.10 |
| |
|
|
|
| F8270 |
Furosemide |
5 g |
$34.50 |
| |
|
10 g |
$58.00 |
| |
A potent diuretic; antihypertensive. Found to have anti-inflammatory effect |
25 g |
$110.40 |
| |
through inhibition of cytokines and tumor necrosis factor-alpha. |
|
|
| |
Prandota J. Am J Ther. 9:317-28 (2002). |
|
|
| |
Cavaliere F, Masieri S. Curr Drug Targets. 3:197-201 (2002). |
|
|
| |
|
|
|
